Beam Therapeutics Inc
NASDAQ:BEAM
Wall Street
Price Targets
BEAM Price Targets Summary
Beam Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
BEAM
is 51 USD
with a low forecast of 27.27 USD and a high forecast of 81.9 USD.
BEAM Last Price Targets
Beam Therapeutics Inc
The latest public price target was made on Feb 1, 2023 by
Unknown Analyst
from
Cantor Fitzgerald
,
who expects
BEAM
stock to
rise by 168%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Unknown Analyst
Cantor Fitzgerald
|
62
USD
Upside 168% |
1 year ago
Feb 1, 2023
|
Cantor Fitzgerald Initiates Coverage On Beam Therapeutics with Overweight Rating, Announces Price Target of $62
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BEAM's stock price target?
Price Target
51
USD
According to Wall Street analysts, the average 1-year price target for
BEAM
is 51 USD
with a low forecast of 27.27 USD and a high forecast of 81.9 USD.
What is Beam Therapeutics Inc's Revenue forecast?
Projected CAGR
-49%
The
compound annual growth rate
of Beam Therapeutics Inc's revenue for the next 3 years is
-49%.
You don't have any saved screeners yet
